RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • TRC4186, a novel AGE-breaker, improves diabetic cardiomyopathy and nephropathy in Ob-ZSF1 model of type 2 diabetes.

TRC4186, a novel AGE-breaker, improves diabetic cardiomyopathy and nephropathy in Ob-ZSF1 model of type 2 diabetes.

Add to Collection
2009 Jul Others D Joshi, R Gupta, A Dubey, A Shiwalkar… - Journal of …, 2009 - journals.lww.com

Full Author : ['Joshi, Deepa', 'Gupta, Ram', 'Dubey, Amita', 'Shiwalkar, Ajay', 'Pathak, Padmaja', 'Gupta, Ramesh C', 'Chauthaiwale, Vijay', 'Dutt, Chaitanya']
Journal Title : Journal of cardiovascular pharmacology
Chapter : Section3
Journal Year : 2009
Cited by : 63.0

Advanced glycation end products (AGEs) contribute significantly to diabetic complications, both macro- and microvascular. TRC4186 is an AGE-breaker that has been evaluated in vitro and in vivo and shown to reduce AGE burden. The aim of this study was to d..... Read More

Keywords : ["novel agebreaker improve diabetic cardiomyopathy", "type diabetes", "nephropathy", "model"]
PubMed Link : https://journals.lww.com/cardiovascularpharm/fulltext/2009/07000/trc4186,_a_novel_age_breaker,_improves_diabetic.11.aspx
Google Scholar Link : https://scholar.google.com/scholar?cites=13939548986970162730&as_sdt=5,36&sciodt=0,36&hl=en&num=20